Genotype, slow decrease in virus titer during interferon treatment and high degree of sequence variability of hypervariable region are indicative of poor response to interferon treatment in patients with chronic hepatitis type C-Reference-Cited by-同舟云学术

Genotype, slow decrease in virus titer during interferon treatment and high degree of sequence variability of hypervariable region are indicative of poor response to interferon treatment in patients with chronic hepatitis type C

Published:1995-12 Issue:6 Volume:23 Page:648-653
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Chayama Kazuaki,Tsubota Akihito,Arase Yasuji,Saitoh Satoshi,Ikeda Kenji,Matsumoto Toyomi,Hashimoto Michie,Kobayashi Mariko,Kanda Masumi,Morinaga Tsuto,Kumada Hiromitsu

Publisher

Elsevier BV

Subject

Hepatology

Reference17 articles.

1. Recombinant interferon alfa therapy for chronic hepatitis C;Di Bisceglie;N Engl J Med,1989

2. Treatment of chronic hepatitis C with recombinant interferon alfa;Davis;N Engl J Med,1989

3. Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C;Chayama;Hepatology,1991

4. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alfa;Hagiwara;Hepatology,1991

5. Hepatitis C viremia rebound after successful interferon therapy in patients with chronic non-A, non-B, hepatitis;Garson;J Med Virol,1992

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transanal hemorrhoidal dearterialization with mucopexy versus open hemorrhoidectomy in the treatment of hemorrhoids: a meta-analysis of randomized control trials;Techniques in Coloproctology;2016-11-25

2. Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4;Annals of Hepatology;2013-01

3. Non-structural 5A protein of hepatitis C virus induces a range of liver pathology in transgenic mice;The Journal of Pathology;2009-06-18

4. Innate immunity and hepatitis C virus: eluding the host cell defense;Frontiers in Bioscience;2009

5. RNA interference-mediated prevention and therapy for hepatocellular carcinoma;Oncogene;2006-06